Research Achievements
Hideaki Bujo| 2012 | 2011 | 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Unoki-Kubota H‚ Yamagishi S‚ Takeuchi M‚ Bujo H‚ Saito Y. Pyridoxamine‚ an inhibitor of advanced glycation end product (AGE) formation ameliorates insulin resistance in obese‚ type 2 diabetic mice.
Protein Pept Lett. 2010; 17 (9): 1177-1181
Ikeuchi T‚ Hirayama S‚ Miida T‚ Fukamachi I‚ Tokutake T‚ Ebinuma H‚ Takubo K‚ Kaneko H‚ Kasuga K‚ Kakita A‚ Takahashi H‚ Bujo H‚ Saito Y‚ Nishizawa M. Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease.
Dement Geriatr Cogn Disord. 2010; 30 (1): 28-32
Takahashi‚ M.‚ Bujo‚ H.‚ Jiang‚ M.‚ Noike‚ H.‚ Saito‚ Y. and Shirai K. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
Atherosclerosis 2010; 210 (2): 581-584
International Conferences
Bujo‚ H. Novel gene therapy using the autologous preadipocyte transplantation for the patients with LCAT deficiency
Amsterdam University Academic Medical Center (AMC) Vascular Medicine Symposium 2010-8-23 Amsterdam/Hol£ģand
Ogita‚ M.‚ Miyauchi‚ K.‚ Dohi‚ T.‚ Miyazaki‚ T.‚Nakajima‚ N.‚ Yokoyama‚ T.‚ Kojima‚ T.‚ Yokoyama‚ K.‚ Kurata‚ T.‚ Bujo‚ H. and Daida‚ H Impact of Soluble LR11 on Target Lesion Revascularization After Coronary Intervention in Patients with Stable Coronary Artery Disease
American Heart Association Scientific Sessions””2010 2010-11-7 Orlando/U.S.A.
Bujo‚ H. Dyslipidemia and cardiovascular disease
Vietnam Nutrition Association The 5th National Nutrition Scientific Conferenc 2010-11-4 Ho Chi Minh City/Vietnam
